Foghorn Therapeutics Inc (FHTX)

Mar 04, 2026

FHTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026

Mar 03, 2026

TD Cowen Health Care Conference - marketscreener.com

Mar 03, 2026

Mar 02, 2026

Foghorn Therapeutics Inc expected to post a loss of 25 cents a shareEarnings Preview - TradingView

Mar 02, 2026

Feb 28, 2026

Should you avoid Foghorn Therapeutics Inc. stock right nowJuly 2025 Volume & Short-Term Trading Alerts - mfd.ru

Feb 28, 2026

Feb 26, 2026

Foghorn Therapeutics (FHTX) Projected to Post Earnings on Thursday - Defense World

Feb 26, 2026

Feb 24, 2026

Foghorn Therapeutics (FHTX) grants CFO 400,000 stock options - Stock Titan

Feb 24, 2026

Feb 24, 2026

Foghorn Therapeutics (FHTX) CFO files Form 3 insider ownership - Stock Titan

Feb 24, 2026

Feb 24, 2026

Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences - Investing News Network

Feb 24, 2026

Feb 24, 2026

Foghorn Therapeutics names Ryan Maynard as chief financial officer By Investing.com - Investing.com India

Feb 24, 2026

Feb 24, 2026

Cancer-focused biotech Foghorn to present at two March investor forums - Stock Titan

Feb 24, 2026

Feb 24, 2026

FHTXFoghorn Therapeutics Inc. Latest Stock News & Market Updates - Stock Titan

Feb 24, 2026

Feb 23, 2026

Foghorn Therapeutics names Ryan Maynard as chief financial officer - Investing.com

Feb 23, 2026

Feb 23, 2026

Foghorn Therapeutics (FHTX) Appoints New CFO with Extensive Expe - GuruFocus

Feb 23, 2026

Feb 23, 2026

Foghorn Therapeutics Appoints Ryan Maynard CFO - marketscreener.com

Feb 23, 2026

Feb 23, 2026

Foghorn Therapeutics Names Veteran Executive as New CFO - TipRanks

Feb 23, 2026

Feb 23, 2026

Foghorn Therapeutics Inc. Appoints Ryan Maynard as Chief Financial Officer - Quiver Quantitative

Feb 23, 2026

Feb 23, 2026

Ryan Maynard joins Foghorn Therapeutics (NASDAQ: FHTX) as new CFO - Stock Titan

Feb 23, 2026

Feb 23, 2026

Foghorn Therapeutics Inc. Announces Executive Changes - marketscreener.com

Feb 23, 2026

Feb 20, 2026

Will Foghorn Therapeutics Inc. (FHTX) Report Negative Q4 Earnings? What You Should Know - MSN

Feb 20, 2026

Feb 20, 2026

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Qiagen (QGEN) and Foghorn Therapeutics (FHTX) - The Globe and Mail

Feb 20, 2026

Feb 19, 2026

Investment Review: Does Aris Mining Corporation have a competitive edgeQuarterly Portfolio Summary & Verified Entry Point Detection - baoquankhu1.vn

Feb 19, 2026

Feb 19, 2026

Jefferies Financial Group Begins Coverage on Foghorn Therapeutics (NASDAQ:FHTX) - Defense World

Feb 19, 2026

Feb 17, 2026

Jefferies Lowers Price Target for Foghorn Therapeutics (FHTX) to $12.00 | FHTX Stock News - GuruFocus

Feb 17, 2026

Feb 17, 2026

Jefferies initiates Foghorn Therapeutics stock with buy rating By Investing.com - Investing.com Nigeria

Feb 17, 2026

Feb 17, 2026

Jefferies initiates Foghorn Therapeutics stock with buy rating - Investing.com

Feb 17, 2026

Feb 16, 2026

Can Foghorn Therapeutics Inc. stock double in the next yearProduct Launch & High Accuracy Investment Signals - mfd.ru

Feb 16, 2026

Feb 15, 2026

Foghorn Therapeutics appoints interim CFO Jeff Sacher - MSN

Feb 15, 2026

Feb 14, 2026

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Average Rating of "Buy" from Brokerages - MarketBeat

Feb 14, 2026

Feb 14, 2026

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Average Rating of “Buy” from Brokerages - Defense World

Feb 14, 2026

Feb 13, 2026

Foghorn Therapeutics CEO Talks Lilly-Partnered SMARCA2 Phase 1 and New Degrader Targets at Conference - MarketBeat

Feb 13, 2026

Feb 12, 2026

Does Foghorn Therapeutics Inc. have strong fundamentalsWeekly Trade Report & Verified Short-Term Plans - mfd.ru

Feb 12, 2026

Feb 12, 2026

Foghorn Therapeutics (NASDAQ:FHTX) Stock Price Down 0.6%Should You Sell? - MarketBeat

Feb 12, 2026

Feb 08, 2026

Foghorn Therapeutics: Key Catalysts on the Horizon for Investors - AD HOC NEWS

Feb 08, 2026

Feb 03, 2026

Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit - Investing News Network

Feb 03, 2026

Feb 01, 2026

Flagship Pioneering Appoints Paul Owen as CEO-Partner and CEO of YourBio Health - Quantisnow

Feb 01, 2026

Jan 18, 2026

Foghorn Therapeutics Reports Q3 2025 Financial Results - MSN

Jan 18, 2026

Jan 17, 2026

Flagship Pioneering Appoints Rahul Kakkar as CEO-Partner and CEO of Quotient Therapeutics - Quantisnow

Jan 17, 2026

Jan 17, 2026

Foghorn Therapeutics (NASDAQ:FHTX) Shares Down 4.1%Time to Sell? - MarketBeat

Jan 17, 2026

Jan 14, 2026

Highs Report: Can Foghorn Therapeutics Inc maintain sales growth2025 Market WrapUp & AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Jan 14, 2026

Jan 14, 2026

Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff - Benzinga

Jan 14, 2026

Jan 13, 2026

Foghorn Therapeutics stock reaffirmed as Buy by BTIG, named top pick for 1H26 - Investing.com Canada

Jan 13, 2026

Jan 13, 2026

Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium - GlobeNewswire

Jan 13, 2026

Jan 12, 2026

Stifel reiterates Buy rating on Foghorn Therapeutics stock at $12 target - Investing.com Canada

Jan 12, 2026

Jan 12, 2026

Foghorn Therapeutics Announces $50 Million Equity Financing - TipRanks

Jan 12, 2026

Jan 12, 2026

Is Foghorn Therapeutics (NASDAQ:FHTX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Jan 12, 2026

Jan 10, 2026

Insider Trends: Will Foghorn Therapeutics Inc stock benefit from green energy trendsJuly 2025 Review & Real-Time Stock Movement Alerts - Bộ Nội Vụ

Jan 10, 2026

Jan 10, 2026

What momentum indicators show for Foghorn Therapeutics Inc. stockJuly 2025 Catalysts & Safe Entry Trade Signal Reports - ulpravda.ru

Jan 10, 2026